Spect Equipment Market Scope And Analysis

SPECT Equipment Market Report Scope

 

The SPECT equipment market has been segmented as follows:

The SPECT equipment market is segmented on the basis of type, radioisotope type, application, end user, and geography. Based on type, the market is bifurcated into hybrid SPECT and standalone SPECT. The market for the hybrid SPECT segment is further bifurcated into SPECT-CT and SPECT-MR. Based on radioisotope type, the SPECT equipment market is segmented into Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, and Others. Based on application, the market is segmented into seizures, stroke, stress fractures, infections, tumors, and others. In terms of end user, the SPECT equipment market is segmented into hospitals, imaging centers, and others. By geography, the market is segmented into North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South & Central America (SCAM). The SPECT equipment market in North America is subsegmented into the US, Canada, and Mexico. The market in Europe is further segmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The SPECT equipment market in Asia Pacific (APAC) is subsegmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. The market in the Middle East & Africa (MEA) is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. The SPECT equipment market in South and Central America (SCAM) is subsegmented into Brazil, Argentina, and the Rest of South and Central America. Company participants included in our research scope areCardinal Health Inc, Curium, Lantheus Medical Imaging, Inc.

,

Mediso Ltd

,

NTP Radioisotopes

,

Bracco Imaging S.p.A, Star Equity Holdings, Inc.

,

Bruker Corporation, MiE GmbH and Spectrum Dynamics Medical amongst others.